The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Demyelination, Inflammation, and Neurodegeneration in Multiple Sclerosis Deep Gray Matter
Open accessAbstract
Gray matter (GM) lesions are recognized as important components of the pathology of multiple sclerosis (MS), and involvement of the deep gray matter (DGM) is suggested by magnetic resonance imaging. The aims of this study were to determine the frequency and distribution of lesions and characterize the inflammatory and neurodegenerative changes in DGM of MS patients. Histochemistry, immunohistochemistry, and morphometry were performed on whole coronal sections of 14 MS and 12 control (6 normal, 6 from amyotrophic lateral sclerosis patients) brains. Demyelinating lesions were frequent in MS DGM; most often in the thalamus and caudate, but they were also seen in the putamen, pallidum, claustrum, amygdala, hypothalamus, and substantia nigra. Most DGM lesions involved both GM and white matter. Inflammation in active DGM lesions was similar to that in lesions only in white matter but was less intense, and there was a preponderance of activated microglia, scarce myelin-laden macrophages, and a lesser extent of axonal damage. Neuronal loss was observed both in DGM lesions and nondemyelinated DGM with neuron atrophy in nondemyelinated DGM. In conclusion, demyelination and neurodegenerative changes are common in MS DGM and may contribute to clinical impairment. Inflammation in DGM lesions is intermediate between the destructive inflammation of white matter lesions and the minimal inflammation of cortical lesions. We hypothesize that alterations of glutamate reuptake mechanisms may contribute to these differences.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Estimation of nuclear population from microtome sections
Abercrombie, M. (1946) · The Anatomical Record · doi:10.1002/ar.1090940210 · Cited by 4,363
Danbolt, N. C. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00067-8 · Cited by 4,227
Rothstein, J. D., Dykes-Hoberg, M., Pardo, C. A., Bristol, L. A., Jin, L., Kuncl, R. W., Kanai, Y., Hediger, M. A., Wang, Y., Schielke, J. P., et al. (1996) · Neuron · doi:10.1016/s0896-6273(00)80086-0 · Cited by 2,534
Cortical demyelination and diffuse white matter injury in multiple sclerosis
Kutzelnigg, A., Lucchinetti, C. F., Stadelmann, C., Brück, W., Rauschka, H., Bergmann, M., Schmidbauer, M., Parisi, J. E., & Lassmann, H. (2005) · Brain · doi:10.1093/brain/awh641 · Cited by 1,836
Peterson, J. W., Bö, L., Mörk, S., Chang, A., & Trapp, B. D. (2001) · Annals of Neurology · doi:10.1002/ana.1123 · Cited by 1,403 · cited 4×
“structures in MS brains including cerebral cortex (1, 2, 45), cerebellar cortex (5), and hippocampus (8).”
BackgroundMethodInfluentialDown-Regulation of the Macrophage Lineage Through Interaction with OX2 (CD200)
Hoek, R. M., Ruuls, S. R., Murphy, C. A., Wright, G. J., Goddard, R., Zurawski, S. M., Blom, B., Homola, M. E., Streit, W. J., Brown, M. H., et al. (2000) · Science · doi:10.1126/science.290.5497.1768 · Cited by 1,022
Subpial Demyelination in the Cerebral Cortex of Multiple Sclerosis Patients
Bø, L., Vedeler, C. A., Nyland, H. I., Trapp, B. D., & Mørk, S. J. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.7.723 · Cited by 757 · cited 3×
“structures in MS brains including cerebral cortex (1, 2, 45), cerebellar cortex (5), and hippocampus (8).”
BackgroundThalamic atrophy and cognition in multiple sclerosis
Houtchens, M. K., Benedict, R. H. B., Killiany, R., Sharma, J., Jaisani, Z., Singh, B., Weinstock-Guttman, B., Guttmann, C. R. G., & Bakshi, R. (2007) · Neurology · doi:10.1212/01.wnl.0000276992.17011.b5 · Cited by 496
Thalamic neurodegeneration in multiple sclerosis
Cifelli, A., Arridge, M., Jezzard, P., Esiri, M. M., Palace, J., & Matthews, P. M. (2002) · Annals of Neurology · doi:10.1002/ana.10326 · Cited by 490
Werner, P., Pitt, D., & Raine, C. S. (2001) · Annals of Neurology · doi:10.1002/ana.1077 · Cited by 486
Intracortical multiple sclerosis lesions are not associated with increased lymphocyte infiltration
Bø, L., Vedeler, C. A., Nyland, H., Trapp, B. D., & Mørk, S. J. (2003) · Multiple Sclerosis Journal · doi:10.1191/1352458503ms917oa · Cited by 478
Neocortical neuronal, synaptic, and glial loss in multiple sclerosis
Wegner, C., Esiri, M. M., Chance, S. A., Palace, J., & Matthews, P. M. (2006) · Neurology · doi:10.1212/01.wnl.0000237551.26858.39 · Cited by 441
Cortical lesions in multiple sclerosis: combined postmortem MR imaging and histopathology.
Geurts, J. J. G., Bø, L., Pouwels, P. J. W., Castelijns, J. A., Polman, C. H., & Barkhof, F. (2005) · PubMed · Cited by 407
Peroxynitrite Inhibits Glutamate Transporter Subtypes
Trotti, D., Rossi, D., Gjesdal, O., Levy, L. M., Racagni, G., Danbolt, N. C., & Volterra, A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.11.5976 · Cited by 372
Benedict, R. H. B., Weinstock-Guttman, B., Fishman, I., Sharma, J., Tjoa, C. W., & Bakshi, R. (2004) · Archives of Neurology · doi:10.1001/archneur.61.2.226 · Cited by 367
Widespread Demyelination in the Cerebellar Cortex in Multiple Sclerosis
Kutzelnigg, A., Faber‐Rod, J. C., Bauer, J., Lucchinetti, C. F., Sorensen, P. S., Laursen, H., Stadelmann, C., Brück, W., Rauschka, H., Schmidbauer, M., et al. (2007) · Brain Pathology · doi:10.1111/j.1750-3639.2006.00041.x · Cited by 336
Glantz, L. A. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830220065010 · Cited by 330
Cortical and subcortical patterns of synaptophysinlike immunoreactivity in Alzheimer's disease.
Masliah, E., Terry, R. D., Alford, M. F., DeTeresa, R. M., & Hansen, L. A. (1991) · PubMed · Cited by 328
Staging of multiple sclerosis (MS) lesions: pathology of the time frame of MS
Van Der Valk, P., & De Groot, C. J. A. (2000) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.2000.00217.x · Cited by 306
Neuron-mediated generation of regulatory T cells from encephalitogenic T cells suppresses EAE
Liu, Y., Teige, I., Birnir, B., & Issazadeh-Navikas, S. (2006) · Nature Medicine · doi:10.1038/nm1402 · Cited by 303
Grey Matter Pathology in Multiple Sclerosis
Vercellino, M., Plano, F., Votta, B., Mutani, R., Giordana, M. T., & Cavalla, P. (2005) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/01.jnen.0000190067.20935.42 · Cited by 295
Self-citationExtensive Hippocampal Demyelination in Multiple Sclerosis
Geurts, J. J. G., Bö, L., Roosendaal, S. D., Hazes, T., Daniëls, R., Barkhof, F., Witter, M. P., Huitinga, I., & van der Valk, P. (2007) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/nen.0b013e3181461f54 · Cited by 287
Masliah, E., Terry, R. D., Alford, M., & DeTeresa, R. (1990) · Journal of Histochemistry & Cytochemistry · doi:10.1177/38.6.2110586 · Cited by 267
Bö, L., Mörk, S., Kong, P. A., Nyland, H., Pardo, C. A., & Trapp, B. D. (1994) · Journal of Neuroimmunology · doi:10.1016/0165-5728(94)90075-2 · Cited by 256
Regional grey matter atrophy in clinically isolated syndromes at presentation
Henry, R. G., Shieh, M., Okuda, D. T., Evangelista, A., Gorno-Tempini, M. L., & Pelletier, D. (2008) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2007.134825 · Cited by 238
Cytokine modulation of glial glutamate uptake: a possble involvement of nitric oxide
Ye, Z.-C., & Sontheimer, H. (1996) · NeuroReport · doi:10.1097/00001756-199609020-00025 · Cited by 211
Substantial Archaeocortical Atrophy and Neuronal Loss in Multiple Sclerosis
Papadopoulos, D., Dukes, S., Patel, R., Nicholas, R., Vora, A., & Reynolds, R. (2009) · Brain Pathology · doi:10.1111/j.1750-3639.2008.00177.x · Cited by 192
Brink, B. P., Veerhuis, R., Breij, E. C. W., van der Valk, P., Dijkstra, C. D., & Bö, L. (2005) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/64.2.147 · Cited by 191
Vercellino, M., Merola, A., Piacentino, C., Votta, B., Capello, E., Mancardi, G. L., Mutani, R., Giordana, M. T., & Cavalla, P. (2007) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31812571b0 · Cited by 190
Self-citationThe blood-brain barrier in cortical multiple sclerosis lesions
van Horssen, J., Brink, B. P., de Vries, H. E., van der Valk, P., & Bø, L. (2007) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e318040b2de · Cited by 187
Thalamic neurodegeneration in relapsing-remitting multiple sclerosis
Wylezinska, M., Cifelli, A., Jezzard, P., Palace, J., Alecci, M., & Matthews, P. M. (2003) · Neurology · doi:10.1212/01.wnl.0000069464.22267.95 · Cited by 186
Grey matter loss in relapsing–remitting multiple sclerosis: A voxel-based morphometry study
Prinster, A., Quarantelli, M., Orefice, G., Lanzillo, R., Brunetti, A., Mollica, C., Salvatore, E., Morra, V. B., Coppola, G., Vacca, G., et al. (2006) · NeuroImage · doi:10.1016/j.neuroimage.2005.08.034 · Cited by 175
Gray, E., Thomas, T. L., Betmouni, S., Scolding, N., & Love, S. (2008) · Brain Pathology · doi:10.1111/j.1750-3639.2007.00110.x · Cited by 175
Sepulcre, J., Sastre-Garriga, J., Cercignani, M., Ingle, G. T., Miller, D. H., & Thompson, A. J. (2006) · Archives of Neurology · doi:10.1001/archneur.63.8.1175 · Cited by 172
Mott, R. T., Ait‐Ghezala, G., Town, T., Mori, T., Vendrame, M., Zeng, J., Ehrhart, J., Mullan, M., & Tan, J. (2004) · Glia · doi:10.1002/glia.20009 · Cited by 170
Inglese, M., Park, S. J., Johnson, G., Babb, J. S., Miles, L., Jaggi, H., Herbert, J., & Grossman, R. I. (2007) · Archives of Neurology · doi:10.1001/archneur.64.2.196 · Cited by 158
Evidence of thalamic gray matter loss in pediatric multiple sclerosis
Mesaroš, Š., Rocca, M. A., Absinta, M., Ghezzi, A., Milani, N., Moiola, L., Veggiotti, P., Comı, G., & Filippi, M. (2008) · Neurology · doi:10.1212/01.wnl.0000291010.54692.85 · Cited by 153
Gilmore, C. P., Bø, L., Owens, T., Lowe, J. S., Esiri, M. M., & Evangelou, N. (2006) · Brain Pathology · doi:10.1111/j.1750-3639.2006.00018.x · Cited by 147
Chitnis, T., Imitola, J., Wang, Y., Elyaman, W., Chawla, P., Sharuk, M., Raddassi, K., Bronson, R. T., & Khoury, S. J. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.060677 · Cited by 146
Altered expression of glutamate transporters in experimental autoimmune encephalomyelitis
Ohgoh, M. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00029-2 · Cited by 143
Geurts, J. J. G., Reuling, I. E. W., Vrenken, H., Uitdehaag, B. M. J., Polman, C. H., Castelijns, J. A., Barkhof, F., & Pouwels, P. J. W. (2006) · Magnetic Resonance in Medicine · doi:10.1002/mrm.20792 · Cited by 136
Acute up‐regulation of glutamate uptake mediated by mGluR5a in reactive astrocytes
Vermeiren, C., Najimi, M., Vanhoutte, N., Tilleux, S., de Hemptinne, I., Maloteaux, J., & Hermans, E. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03216.x · Cited by 128
Meuth, S. G., Simon, O. J., Grimm, A. M., Melzer, N., Herrmann, A. M., Spitzer, P., Landgraf, P., & Wiendl, H. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2007.11.013 · Cited by 124
Excitotoxic oligodendrocyte death and axonal damage induced by glutamate transporter inhibition
Domercq, M., Etxebarria, E., Pérez‐Samartín, A., & Matute, C. (2005) · Glia · doi:10.1002/glia.20221 · Cited by 121
Selective caudate atrophy in multiple sclerosis: a 3D MRI parcellation study
Bermel, R. A., Innus, M., Tjoa, C. W., & Bakshi, R. (2003) · Neuroreport · doi:10.1097/00001756-200303030-00008 · Cited by 111
Ginsberg, S. D., & Martin, L. J. (2002) · Journal of Neurotrauma · doi:10.1089/089771502753460277 · Cited by 75
Does high-field MR imaging improve cortical lesion detection in multiple sclerosis?
Geurts, J. J. G., Blezer, E. L. A., Vrenken, H., van der Toorn, A., Castelijns, J. A., Polman, C. H., Pouwels, P. J. W., Bø, L., & Barkhof, F. (2008) · Journal of Neurology · doi:10.1007/s00415-008-0620-5 · Cited by 66
Law, A. J., & Harrison, P. J. (2003) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(03)00075-x · Cited by 65
Axon reaction in the red nucleus of the rat
Egan, D. A., Flumerfelt, B. A., & Gwyn, D. G. (1977) · Acta Neuropathologica · doi:10.1007/bf00684534 · Cited by 53
Patrizio, M., & Levi, G. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90755-2 · Cited by 47
Movement disorders in multiple sclerosis: causal or coincidental association?
Nociti, V., Bentivoglio, A. R., Frisullo, G., Fasano, A. A., Soleti, F., Iorio, R., Loria, G., Patanella, A. K., Marti, A., Tartaglione, T., et al. (2008) · Multiple Sclerosis Journal · doi:10.1177/1352458508094883 · Cited by 42
Cited by
Filippi, M., Bar-Or, A., Piehl, F., Preziosa, P., Solari, A., Vukusic, S., & Rocca, M. A. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0041-4 · Cited by 1,562
Pathological mechanisms in progressive multiple sclerosis
Mahad, D. H., Trapp, B. D., & Lassmann, H. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70256-x · Cited by 1,137
Lassmann, H. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a028936 · Cited by 937
Pathogenic Mechanisms Associated With Different Clinical Courses of Multiple Sclerosis
Lassmann, H. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2018.03116 · Cited by 663
Progressive multiple sclerosis: from pathogenic mechanisms to treatment
Correale, J., Gaitán, M. I., Ysrraelit, M. C., & Fiol, M. P. (2016) · Brain · doi:10.1093/brain/aww258 · Cited by 573
Metadata
- Authors
- Vercellino, M., Masera, S., Lorenzatti, M., Condello, C., Merola, A., Mattioda, A., Tribolo, A., Capello, E., Mancardi, G. L., Mutani, R., Giordana, M. T., & Cavalla, P.
- Venue
- Journal of Neuropathology & Experimental Neurology
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-05
- Volume
- 68
- Issue
- 5
- Pages
- 489-502
- ISSN
- 0022-3069 (ISSN-L)
- 1554-6578
- OpenAlex
- W1980540422
- Cited by
- 277
- References
- 51
- FWCI
- 10.94
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.